AEON Biopharma annual total assets
2021
2022
2023
2024
2025
AEON Biopharma Total Assets Growth & History (AEON)
AEON Biopharma's total assets was $5.6M for fiscal 2025.
View full AEON Biopharma company overviewAEON Biopharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.6M | $2.4M | +76.96% |
| 2024 | 2024-12-31 | $3.1M | −$3.7M | −54.10% |
| 2023 | 2023-12-31 | $6.8M | −$3.9M | −36.49% |
| 2022 | 2022-12-31 | $10.8M | −$266.2M | −96.11% |
| 2021 | 2021-12-31 | $276.9M | — | — |
AEON Biopharma quarterly total assets
As of Dec 31, 2020
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.9M | −$5.8M | −49.32% |
| Q1 2026 | 2026-03-31 | $8.6M | −$5.2M | −37.46% |
| Q4 2025 | 2025-12-31 | $5.6M | $2.4M | +76.96% |
| Q3 2025 | 2025-09-30 | $8.7M | $4.7M | +118.13% |
| Q2 2025 | 2025-06-30 | $11.7M | $5.9M | +103.38% |
| Q1 2025 | 2025-03-31 | $13.8M | $10.8M | +355.11% |
| Q4 2024 | 2024-12-31 | $3.1M | −$3.7M | −54.10% |
| Q3 2024 | 2024-09-30 | $4.0M | −$13.6M | −77.27% |
| Q2 2024 | 2024-06-30 | $5.7M | −$16.1M | −73.68% |
| Q1 2024 | 2024-03-31 | $3.0M | −$18.6M | −85.97% |
| Q4 2023 | 2023-12-31 | $6.8M | −$3.9M | −36.49% |
| Q3 2023 | 2023-09-30 | $17.6M | −$259.7M | −93.65% |
| Q2 2023 | 2023-06-30 | $21.8M | −$254.7M | −92.12% |
| Q1 2023 | 2023-03-31 | $21.6M | −$255.0M | −92.19% |
| Q4 2022 | 2022-12-31 | $10.8M | −$266.2M | −96.11% |
| Q3 2022 | 2022-09-30 | $277.3M | $119,575 | +0.04% |
| Q2 2022 | 2022-06-30 | $276.5M | −$1.1M | −0.40% |
| Q1 2022 | 2022-03-31 | $276.6M | −$1.5M | −0.54% |
| Q4 2021 | 2021-12-31 | $276.9M | $276.9M | +341813.00% |
| Q3 2021 | 2021-09-30 | $277.2M | — | — |
| Q2 2021 | 2021-06-30 | $277.6M | — | — |
| Q1 2021 | 2021-03-31 | $278.1M | — | — |
| As of Dec 31, 2020 | 2020-12-31 | $81,000 | — | — |
AEON Biopharma total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, AEON Biopharma's total assets decreased from $276.9M to $5.6M, a change of −$271.4M. The latest reported quarter, Q2 2026, shows $5.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AEON Biopharma source filings ↗